February 16, 2024 · Form 4 insider transaction
JOHNSON & JOHNSON bought 607,725 shares of CVRx, Inc. at $0.16 per share, a transaction worth $96.0K. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 19 days after the transaction.
The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson.